Maya is an Investment Analyst at Angelini Ventures based in London, involved in sourcing and closing investments and assisting with fund strategic initiatives.

Previously, Maya worked for Goldman Sachs as an investment banking analyst in London, focusing on M&A transactions across geographies including Europe, the Middle East, and the US. Her experience ranges from MedTech to SaaS platforms to asset-heavy renewables companies.

She has also worked with a women's health startup improving contraceptive matching, there she helped define product design, pricing, and go-to-market strategy.

She holds a Master in Biochemistry from the University of Oxford, her research focused on early drug discovery to target neurodegeneration in lysosomal storage diseases.